Cue Biopharma Balance Sheet (2016-2026)

Reported Financials

Cue Biopharma Quarterly Balance Sheet

Periods 39 quarters

Latest Jun 2026

Cue Biopharma reported total assets of $30.71M and total liabilities of $28.40M for the quarter ended Jun 2026, down 24.6% year over year. This balance sheet covers 39 quarters of results from Dec 2016 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	67.63M	64.37M	67.93M	66.13M	29.73M	51.61M	56.32M	52.90M	54.69M	48.51M	41.03M	30.03M	32.42M	22.46M	13.14M	27.49M	11.70M	27.14M	16.40M	17.40M
Short-term InvestmentsInvestments (Current)					29.46M	24.68M	9.88M	4.99M									7.00M
Cash & Current Investments	67.63M	64.37M	67.93M	66.13M	59.18M	76.29M	66.20M	57.89M	54.69M	48.51M	41.03M	30.03M	32.42M	22.46M	13.14M	27.49M	18.70M	27.14M	16.40M	17.40M
Receivables - NetNet Receivables	0.77M	3.14M	0.93M	0.74M	0.80M	0.06M	0.20M	1.14M	1.66M	1.70M	1.40M	1.85M	3.15M	0.95M		0.53M	0.39M	5.55M	5.35M	5.38M
Receivables	0.77M	3.14M	0.93M	0.74M	0.80M	0.06M	0.20M	1.14M	1.66M	1.70M	1.40M	1.85M	3.15M	0.95M		0.53M	0.39M	5.55M	5.35M	5.38M
Prepaid Assets	1.85M	0.95M	1.97M	2.14M	1.72M	0.84M	2.36M	1.91M	1.17M	0.96M	2.24M	2.02M	1.68M	0.81M	1.88M	2.35M	3.11M	1.31M	1.70M	1.93M
Current Assets	70.26M	68.47M	75.95M	69.00M	61.70M	77.19M	68.76M	60.94M	57.52M	51.45M	44.67M	33.90M	37.26M	25.14M	15.93M	30.84M	25.82M	36.98M	26.39M	26.62M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)	2.34M	2.11M	1.92M	1.77M	1.64M	1.50M	1.33M	1.19M	1.06M	0.80M	0.75M	0.67M	0.57M	0.47M	0.52M	0.45M	0.31M	0.24M	0.29M	0.26M
Long-Term Investments										6.32M				4.37M				4.07M
Intangibles
Goodwill & Intangibles
Other Non-Current Assets	2.91M	3.01M	2.96M	4.08M	3.40M	3.39M	3.10M	3.25M	3.25M	2.96M	2.96M	2.95M	2.95M	2.21M	2.21M	2.39M	0.92M	0.91M	0.88M	0.87M
Non-Current Assets	8.62M	14.93M	14.76M	15.75M	14.60M	14.10M	12.93M	12.23M	11.37M	10.08M	9.28M	8.43M	7.55M	7.05M	6.32M	9.86M	5.83M	5.23M	4.49M	4.08M
Assets	78.88M	83.40M	90.70M	84.75M	76.30M	91.28M	81.68M	73.16M	68.89M	61.53M	53.95M	42.33M	44.81M	32.19M	22.25M	40.71M	31.64M	42.21M	30.88M	30.71M
Liabilities
Current Liabilities
Accounts Payables	2.47M	2.59M	2.62M	1.57M	2.05M	2.73M	2.15M	2.36M	2.48M	3.50M	3.92M	3.91M	6.47M	2.82M	3.78M	3.63M	2.35M	3.95M	3.33M	3.75M
Payables	2.47M	2.59M	2.62M	1.57M	2.05M	2.73M	2.15M	2.36M	2.48M	3.50M	3.92M	3.91M	6.47M	2.82M	3.78M	3.63M	2.35M	3.95M	3.33M	3.75M
Accumulated Expenses	3.99M	4.62M	3.41M	3.56M	3.88M	3.55M	2.84M	4.08M	5.13M	4.14M	5.21M	4.56M	3.20M	2.91M	4.23M	1.52M	1.87M	1.61M	1.50M	14.88M
Other Accumulated Expenses										3.37M	3.21M	3.05M	2.90M	3.54M	0.54M	2.11M	2.03M	1.91M	1.56M	1.63M
Short term Debt					1.96M	1.96M	5.96M	7.96M	7.96M	3.96M	7.96M	7.96M	7.96M	4.33M	3.37M	2.42M	1.46M	0.69M	1.00M	0.96M
Current Deferred Revenue
Total Current Liabilities	15.36M	12.79M	11.41M	8.32M	10.22M	11.55M	13.81M	16.31M	17.21M	17.08M	18.09M	16.46M	16.79M	13.69M	15.50M	19.25M	15.52M	13.49M	7.39M	21.22M
Non-Current Liabilities
Non-Current Debt			9.86M	9.91M	8.99M	8.04M	7.08M	6.12M	5.16M	4.20M	3.24M	2.29M	1.33M			0.19M	0.19M
Operating Leases	3.63M	5.12M	4.76M	6.76M	6.32M	6.02M	3.16M	4.60M	3.86M	3.16M	2.58M	1.96M	1.33M	1.00M	0.18M	3.10M	2.68M	2.29M	1.88M	1.45M
Other Non-Current Liabilities	5.26M						2.52M	2.55M	2.24M	2.11M	1.79M	0.98M	0.26M	0.09M		9.58M	7.82M	5.34M
Total Non-Current Liabilities	10.09M	17.91M		24.99M	25.54M	25.60M	24.14M	24.61M	23.98M	22.33M	22.12M	19.73M	19.19M	14.61M	15.67M	12.97M	10.58M	10.45M	9.27M	28.40M
Total Liabilities	15.36M	17.91M	26.03M	24.99M	25.54M	25.60M	26.67M	27.16M	26.22M	24.45M	23.91M	20.71M	19.44M	14.69M	15.67M	22.55M	18.40M	15.78M	9.27M	28.40M
Shareholder's Equity
Total Debt			9.86M	9.91M	10.96M	10.00M	13.04M	14.08M	13.12M	8.17M	11.21M	10.25M	9.29M	4.33M	3.37M	2.61M	1.65M	0.69M	1.00M	0.96M
Common Equity	63.52M	65.49M	64.67M	59.76M	50.76M	65.68M	55.02M	46.00M	42.67M	37.09M	30.04M	21.62M	25.37M	17.50M	6.58M	18.16M	13.25M	26.43M	21.61M	2.31M
Liabilities and Shareholders Equity	78.88M	83.40M	90.70M	84.75M	76.30M	91.28M	81.68M	73.16M	68.89M	61.53M	53.95M	42.33M	44.81M	32.19M	22.25M	40.71M	31.64M	42.21M	30.88M	30.71M
Retained Earnings	-189.06M	-197.45M	-211.70M	-224.91M	-235.86M	-250.46M	-263.57M	-276.75M	-287.76M	-301.19M	-313.54M	-323.71M	-332.37M	-341.86M	-354.12M	-362.60M	-370.05M	-368.47M	-373.64M	-526.71M

Cue Biopharma Balance Sheet API

Pull Cue Biopharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CUE&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "CUE", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=CUE&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

Cue Biopharma CUE Balance Sheet (2016-2026)

Cue Biopharma Quarterly Balance Sheet

Cue Biopharma Balance Sheet API

Create an account

Sign In

Reset Password